发明申请
- 专利标题： Erythropoietin Expression Promoter
- 专利标题（中）： 红细胞生成素表达启动子
-
申请号： US14646640申请日： 2013-11-25
-
公开(公告)号： US20150353489A1公开(公告)日： 2015-12-10
- 发明人: Takaaki ABE , Teiji TOMINAGA , Kenichiro HAYASHI , Hitoshi OSAKA
- 申请人： TOHOKU UNIVERSITY , KAKE EDUCATIONAL INSTITUTION , KANAGAWA PREFECTURAL HOSPITAL ORGANIZATION KANAGAWA CHILRDEN'S MEDICAL CENTER
- 优先权： JP2012-258027 20121126
- 国际申请： PCT/JP2013/006916 WO 20131125
- 主分类号： C07D209/18
- IPC分类号： C07D209/18 ; C07D209/20 ; C07D401/06
摘要：
The present invention provides an erythropoietin expression-enhancing agent that can cancel the suppression of erythropoietin production or promote erythropoietin production, and a therapeutic or preventive drug for anemia, a liver function-improving agent, an ischemic injury-improving agent, a renal protective agent, and an insulin secretagogue comprising the erythropoietin expression-enhancing agent. The erythropoietin expression-enhancing agent of the present invention comprises one or more compounds selected from the group consisting of compounds represented by the following general formulas (I), (II), and (III) and pharmaceutically acceptable salts thereof when R3 is OH.
公开/授权文献
- US10004718B2 Erythropoietin expression promoter 公开/授权日：2018-06-26
信息查询
